首页> 外国专利> Methods for altering mRNA splicing and treating familial dysautonomia by administering benzyladenine

Methods for altering mRNA splicing and treating familial dysautonomia by administering benzyladenine

机译:通过使用苄腺嘌呤改变mRNA剪接和治疗家族性自主神经的方法

摘要

This invention relates to methods for altering the splicing of mRNA in cells. In particular, this invention also relates to methods for increasing the ratio of wild type to misspliced forms of mRNA and corresponding encoded proteins in cells possessing a mutant gene encoding either the i) misspliced mRNA corresponding to the mutant protein or ii) a component in the splicing machinery responsible for processing the misspliced mRNA. In addition, this invention relates to treating individuals having a disorder associated with a misspliced mRNA, such as Familial Dysautonomia or Neurofibromatosis 1, by administering to such an individual a cytokinin such as kinetin.
机译:本发明涉及改变细胞中mRNA剪接的方法。特别地,本发明还涉及用于在具有突变基因的细胞中提高野生型与错接形式的mRNA和相应编码蛋白之比的方法,所述突变基因编码i)与突变蛋白相对应的错剪mRNA或ii)所述突变体中的组分。剪接机器负责处理错接的mRNA。另外,本发明涉及通过对人施用细胞分裂素如激动素来治疗患有与错配的mRNA有关的疾病的个体,例如家族性自主神经自主症或神经纤维瘤病1。

著录项

  • 公开/公告号US9265766B2

    专利类型

  • 公开/公告日2016-02-23

    原文格式PDF

  • 申请/专利权人 THE GENERAL HOSPITAL CORPORATION;

    申请/专利号US201414281065

  • 发明设计人 SUSAN A. SLAUGENHAUPT;JAMES F. GUSELLA;

    申请日2014-05-19

  • 分类号A61K31/52;A61K31/353;A61K31/355;C12Q1/68;

  • 国家 US

  • 入库时间 2022-08-21 14:30:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号